Kotak Leads in Supplement Brand
26 Feb 2026
US$ 20.00
Kotak Alternate Asset Managers Ltd, through its Kotak Life Sciences Fund I, has led the 650 m rupees (US$7.2 m) series...
Related Publications
Subscribers’ Weekly for the week ending 27 Feb 2026...
Listen to Subscribers' Weekly 27 Feb 2026...
Connect With Us
We love to share Asia PE insights and news from time to time. Drop us your email address if you like to hear from us.
Rest assured that your email address will not be shared, as we hate spams as much as you do.